英偉達
NVDA
特斯拉
TSLA
超微電腦
SMCI
4
Palantir
PLTR
5
Applovin
APP
美股市場個股詳情
RNAZ Transcode Therapeutics
- 3.350
- -0.940-21.91%
收盤價 02/26 16:00 (美東)
- 2.860
- -0.490-14.63%
盤後 19:59 (美東)
233.24萬總市值-0.12市盈率TTM
4.230最高價3.000最低價93.39萬股成交量4.000今開4.290昨收318.58萬成交額145.45%換手率0.00市盈率(靜)69.62萬總股本66.33052周最高1.41市淨率215.09萬流通值2.66052周最低--股息TTM64.21萬流通股184800.000歷史最高--股息率TTM28.67%振幅2.660歷史最低3.411平均價1股每手
Transcode Therapeutics所有資訊
Transcode Therapeutics | D：發行公告
Transcode Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-3i, LP(0%),3i Management LLC(0%)等
Transcode Therapeutics | SC 13G：超過5%持股股東披露文件-3i, LP(9.9%),3i Management LLC(9.9%)等
Transcode Therapeutics | SC 13D：超過5%持股股東披露文件-Thomas A. Fitzgerald(5.5%)
Transcode Therapeutics | 4：持股變動聲明-高管 Fitzgerald Thomas A
Transcode Therapeutics | 4：持股變動聲明-董事 Manting Erik
Transcode Therapeutics | 4：持股變動聲明-董事 Marquet Magda
Transcode Therapeutics | 4：持股變動聲明-董事 Calais Philippe
Transcode Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Zdravka Medarova(0.4%)
Transcode Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Tang Capital Partners, LP(0.0%),Tang Capital Management, LLC(0.0%)等
Transcode Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Lind Global Fund II LP(0.1%),Lind Global Partners II LLC(0.1%)等
Transcode Therapeutics | SC 13G：超過5%持股股東披露文件-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%)等
Transcode Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Robert Michael Dudley(1.9%)
Transcode Therapeutics | 4：持股變動聲明-首席財務官 Fitzgerald Thomas A
Transcode Therapeutics | 4：持股變動聲明-首席執行官 Dudley Robert Michael
Transcode Therapeutics | SC 13G：超過5%持股股東披露文件-Tang Capital Partners, LP(9.99%),Tang Capital Management, LLC(9.99%)等
Transcode Therapeutics | 4：持股變動聲明-首席執行官 Dudley Robert Michael
Transcode Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Robert Michael Dudley(6.0%)
Transcode Therapeutics | 4/A：持股變動聲明(修正)-首席執行官 Dudley Robert Michael
Transcode Therapeutics | 4：持股變動聲明-首席執行官 Dudley Robert Michael